158
Views
3
CrossRef citations to date
0
Altmetric
Original Article: Research

10p12.31-12.2 variants and risk of childhood acute lymphoblastic leukemia in a Chinese population

, , , , , , , , & show all
Pages 175-178 | Received 22 Oct 2013, Accepted 29 Mar 2014, Published online: 16 Jun 2014
 

Abstract

Acute lymphoblastic leukemia (ALL) is a clonal hematologic disease, and is the most common cause of childhood malignancy. Recently, a new locus was identified at 10p12.31-12.2 through a genome-wide association study (GWAS) that included racially and ethnically diverse populations. We conducted a replication study with 570 cases of ALL and 673 cancer-free controls to validated the association of this locus with ALL susceptibility in a Chinese population. The results of our study confirmed that the 10p12.31-12.2 locus was linked to childhood ALL susceptibility in the Chinese population. Interestingly, we also found that the single nucleotide polymorphisms (SNPs) in this locus had a larger effect on susceptibility to high-risk ALL than on susceptibility to low-risk ALL.

Acknowledgements

We thank Heng Xu and Jun J. Yang from St. Jude Children's Research Hospital for their generous support. We also thank the National Natural Science Foundation of China (81070436) and Nanjing Special Foundation of Medical Sciences for their support.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.